“…Although higher levels of experiential avoidance have been associated with higher risks of many forms of psychopathology (Levin et al, 2014), the potential of the AAQ-II in discriminating clinical and nonclinical samples has not been adequately demonstrated (Karekla & Michaelides, 2017;Tyndall et al, 2019). In the past decade, there has also been a noticeable trend in developing variations of the AAQ in more disorder-specific manner, in order to evaluate the role of experiential avoidance in particular conditions, including psychosis (Shawyer et al, 2007), chronic pain (Vowles, McCracken, McLeod, & Eccleston, 2008), social anxiety (MacKenzie & Kocovski, 2010), body-image (Sandoz, Wilson, Merwin, & Kellum, 2013), substance abuse (Luoma, Drake, Hayes, & Kohlenberg, 2011), smoking dependence (Gifford et al, 2002), and weight-related issues (Lillis & Hayes, 2008). As much as their results are promising and highlight the importance of experiential avoidance, most of this research was conducted with AAQ, i.e., before the development of the AAQ-II.…”